Contraceptive Technology Update – June 1, 2009
June 1, 2009
View Issues
-
Second-generation female condom OK'd by FDA — What's next for the U.S.?
Female-controlled prevention options are set to expand with the Food and Drug Administration (FDA) March 2009 approval of the second generation of the female condom manufactured by the Female Health Co. -
Interim guidance issued on pregnant women and swine flu
If your practice includes care of pregnant women, be sure to review just-issued interim guidance from the Centers for Disease Control and Prevention (CDC) in regard to swine influenza A (H1N1) virus infection. -
Check option of IUD for emergency contraception
When it comes to emergency contraception (EC), placement of a Copper T 380A intrauterine device [(IUD), ParaGard, Duramed Pharmaceuticals, a subsidiary of Barr Pharmaceuticals; Pomona, NY] offers excellent protection against unwanted pregnancy, as well as long-term contraception. What are some of the roadblocks that may hinder its use? -
Today Sponge sees brighter tomorrow
Women who have been searching for the Today contraceptive sponge on pharmacy shelves can stop hunting: Mayer Laboratories now serves as the U.S. distributor for the over-the-counter contraceptive. -
Get ready for changes in HPV DNA testing
The Food and Drug Administration (FDA) has approved two new tests for human papillomavirus (HPV). How does the addition of these tests affect current practice? -
Washington Watch: Advocates seek support for 'real' sex education
During his 2008 campaign and in the budget framework that President Obama sent to Congress late in February, he signaled his support for a U-turn in federal policy to prevent pregnancy and sexually transmitted infections (STIs) among American youth. -
Plan B OTC access extended to 17-year-olds
The Food and Drug Administration (FDA) is complying with a federal judge's instruction and is directing the manufacturers of the dedicated emergency contraceptive pill Plan B to make the drug available to 17-year-olds without prescription. -
CTU to focus on economic issues in upcoming edition
How is your facility coping with the current economic downturn? Look to the July issue of Contraceptive Technology Update for special focus articles that will report on such up-to-the-moment items as these: -
STD Quarterly: Research update: Male circumcision reduces risk of genital herpes and HPV infection
Findings from two parallel clinical trials in Rakai, Uganda, indicate that heterosexual men who undergo medical circumcision can significantly reduce their risk of acquiring two common sexually transmitted diseases (STDs): herpes simplex virus type 2 (HSV-2) and human papillomavirus (HPV). -
STD Quarterly: Boost efforts to close STD prevention gaps
Sexually transmitted diseases (STDs) remain a major U.S. public health challenge. About 19 million new infections occur each year, with almost half of them among young people ages 15 to 24.1 What are you doing to close the gaps when it comes to STD prevention in this age group?